CRYSTALEST Trademark

Trademark Overview

On Thursday, September 8, 2022, a trademark application was filed for CRYSTALEST with the United States Patent and Trademark Office. The USPTO has given the CRYSTALEST trademark a serial number of 79354642. The federal status of this trademark filing is REGISTERED as of Tuesday, May 7, 2024. This trademark is owned by ESTEVE PHARMACEUTICALS, S.A.. The CRYSTALEST trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research in the field of chemicals, pharmacological and scientific laboratory technology; design and development of medical technology in the field of medical devices and manufacture of chemical pharmaceuticals; medical and pharmacological research services; scientific and technological services, namely, research and design in the field of medical devices and manufacture of chemical pharmaceuticals
crystalest

General Information

Serial Number79354642
Word MarkCRYSTALEST
Filing DateThursday, September 8, 2022
Status700 - REGISTERED
Status DateTuesday, May 7, 2024
Registration Number7376469
Registration DateTuesday, May 7, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 20, 2024

Trademark Statements

Goods and ServicesResearch in the field of chemicals, pharmacological and scientific laboratory technology; design and development of medical technology in the field of medical devices and manufacture of chemical pharmaceuticals; medical and pharmacological research services; scientific and technological services, namely, research and design in the field of medical devices and manufacture of chemical pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 14, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameESTEVE PHARMACEUTICALS, S.A.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressES
Party NameESTEVE PHARMACEUTICALS, S.A.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressES
Party NameESTEVE PHARMACEUTICALS, S.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressES

Trademark Events

Event DateEvent Description
Thursday, June 22, 2023ASSIGNED TO EXAMINER
Thursday, November 10, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, November 14, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 18, 2022APPLICATION FILING RECEIPT MAILED
Saturday, June 24, 2023NON-FINAL ACTION WRITTEN
Sunday, June 25, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, August 1, 2023REFUSAL PROCESSED BY MPU
Tuesday, August 1, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, August 21, 2023REFUSAL PROCESSED BY IB
Friday, December 15, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 15, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, December 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 17, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 17, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, January 17, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, January 17, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, January 17, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 31, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 1, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, February 1, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 7, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 7, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, February 20, 2024PUBLISHED FOR OPPOSITION
Monday, February 26, 2024NOTIFICATION PROCESSED BY IB
Monday, March 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, April 10, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, April 29, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, May 7, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, May 7, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, August 7, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, October 31, 2024FINAL DISPOSITION NOTICE SENT TO IB
Thursday, October 31, 2024FINAL DISPOSITION PROCESSED
Wednesday, April 10, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Related Keywords

crystalest medical research field devices chemical pharmaceuticals manufacture technology pharmacological scientific